Glaukos Announces First Quarter 2023 Financial Results
Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced... | May 3, 2023